The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2

JOURNAL ARTICLE published 1 January 2020 in JAMA Oncology

Authors: George W. Sledge | Masakazu Toi | Patrick Neven | Joohyuk Sohn | Kenichi Inoue | Xavier Pivot | Olga Burdaeva | Meena Okera | Norikazu Masuda | Peter A. Kaufman | Han Koh | Eva-Maria Grischke | PierFranco Conte | Yi Lu | Susana Barriga | Karla Hurt | Martin Frenzel | Stephen Johnston | Antonio Llombart-Cussac